Vimarsana
Biggest News Aggregation in the World

Page 17 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer's Pipeline - Vimarsana News

IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer's Pipeline

IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") today announced that it has appointed Terry Lierman as an independent director to its board of directors. Mr. Lierman is currently Co-Chair of the Board of Advisors at the Institute of Human...

FSD Pharma Submits a Phase-1b Clinical Trial Application for Ethics Committee for its Proprietary Beverage unbuzzd(TM) - Vimarsana News

FSD Pharma Submits a Phase-1b Clinical Trial Application for Ethics Committee for its Proprietary Beverage unbuzzd(TM)

TORONTO, ON / ACCESSWIRE / March 11, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and

12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds - Vimarsana News

12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds

In this article, we discuss 12 most undervalued biotech stocks to buy according to hedge funds.

12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds - Vimarsana News

12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds

In this article, we discuss 12 most undervalued biotech stocks to buy according to hedge funds. If you want to skip our discussion on the biotech industry, head over to 5 Most Undervalued Biotech Stocks To Buy According To Hedge Funds. Fitch Ratings maintains a Neutral outlook for the global pharmaceutical and biotech industry in […]

Source: yahoo.com
Astellas Pharma (OTCMKTS:ALPMY) Share Price Passes Below 50 Day Moving Average of $11.51 - Vimarsana News

Astellas Pharma (OTCMKTS:ALPMY) Share Price Passes Below 50 Day Moving Average of $11.51

Shares of Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Free Report) passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $11.51 and traded as low as $11.00. Astellas Pharma shares last traded at $11.03, with a volume of 237,921 shares traded. Astellas Pharma Stock […]